EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark TARGET COLON was filed as Word mark on 02/08/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/02/2010.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 008865891 |
| Application date | February 8, 2010 |
| Publication date | April 19, 2010 |
| Entry date | August 2, 2010 |
| Expiration date | February 8, 2020 |
Trademark owner
6655 N. MacArthur Blvd
75039 Irving
US
75039 Irving
US
goods and services
10
Pathology and molecular diagnostics specimen collection kits
42
Medical research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, cellular manipulation, light microscopic examination, immunohistochemistry flow cytometry, expression profiling, microarray analysis, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing temporary use of nondownloadable software for tracking laboratory information featuring customized biospecimens and coordinating and conducting follow-on studies to complement the clinical findings; medical and scientific research; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials
44
Medical services; medical testing, diagnostic, theranostic, prognostic and analysis services, including pathology diagnostics, anatomic diagnostics and molecular diagnostics services; medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical services, namely, providing patient history reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, prognosis, and predicting or monitoring therapeutic response for cancer patients; health care services, namely providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes; medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| December 10, 2020 | Extension, Trade mark expired | ||
| September 4, 2019 | Change Representative, Published | ||
| February 1, 2019 | Change Representative, Published | ||
| April 24, 2015 | Change Representative, Published | ||
| October 19, 2010 | Transfer / Change of address, Published | ||
| August 26, 2010 | Transfer / Change of address, Published |
ID: 11008865891